Predict your next investment

Corporation
montgomery.co.uk

See what CB Insights has to offer

Investments

16

Portfolio Exits

4

About Montgomery & Co

Montgomery & Co is based in England, United Kingdom.

Montgomery & Co Headquarter Location

England,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Montgomery & Co

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Montgomery & Co in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Montgomery & Co News

Barclays Appoints David Parrot as Head of US West Coast Biotech Banking

Dec 10, 2018

Mr. Parrot joins Barclays with close to 30 years of experience in banking, most recently as Head of Life Science Investment Banking at SunTrust Robinson Humphrey. Prior to joining SunTrust in 2015, Mr. Parrot was Co-Head of Life Science Investment Banking at BMO Capital Markets. Mr. Parrot joined BMO Capital Markets in 2010 after spending one year at Montgomery & Co., prior to which he was a founding member of the Life Sciences Investment Banking Group at Piper Jaffray & Co., joining in 1998. “As Biotech continues to see rapid and marked evolution, we are excited about the great value David’s experience and abilities will bring to our clients,” said Rick Landgarten, Global Head of Healthcare & Real Estate Groups. “David’s hire is further evidence of our significant investment of resources in our strong Biotech franchise, and his deep and longstanding industry relationships and extensive transactional expertise make him a superb addition to our team.” “Barclays is committed to investing in top talent to enable us to continue to drive mind and market share with our clients, and this is perfectly demonstrated in David’s hire,” added John Miller, Global Head of Banking Coverage. “The Biotech space represents a critical opportunity-set for our investment banking business, and David’s addition to the team will ensure that we continue to build on the strong momentum in our broader Healthcare franchise.” Mr. Parrot is expected to start in early March 2019. Barclays is a transatlantic consumer and wholesale bank offering products and services across personal, corporate and investment banking, credit cards and wealth management, with a strong presence in our two home markets of the UK and the US. With over 325 years of history and expertise in banking, Barclays operates in over 40 countries and employs approximately 80,000 people. Barclays moves, lends, invests and protects money for customers and clients worldwide. For further information about Barclays, please visit our website home.barclays View source version on businesswire.com: https://www.businesswire.com/news/home/20181210005524/en/ Andrew Smith

Montgomery & Co Investments

16 Investments

Montgomery & Co has made 16 investments. Their latest investment was in WEVR as part of their Series A - IV on March 3, 2015.

CBI Logo

Montgomery & Co Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/19/2015

Series A - IV

WEVR

$6.7M

Yes

3

3/5/2013

Series B

Graphiq

$11M

Yes

7

11/16/2010

Unattributed VC - IV

Cardiac Dimensions

$6.45M

No

12/10/2007

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

9/24/2007

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/19/2015

3/5/2013

11/16/2010

12/10/2007

9/24/2007

Round

Series A - IV

Series B

Unattributed VC - IV

Unattributed VC - III

Series C

Company

WEVR

Graphiq

Cardiac Dimensions

Subscribe to see more

Subscribe to see more

Amount

$6.7M

$11M

$6.45M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

7

10

10

Montgomery & Co Portfolio Exits

4 Portfolio Exits

Montgomery & Co has 4 portfolio exits. Their latest portfolio exit was Graphiq on July 20, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/20/2017

Acquired

$991

4

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

7/20/2017

00/00/0000

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.